Smith & Nephew (SN.)

Sector:

Health Care

Index:

FTSE 100

986.00p
   
  • Change Today:
      9.20p
  • 52 Week High: 1,208.50
  • 52 Week Low: 917.60
  • Currency: UK Pounds
  • Shares Issued: 874.38m
  • Volume: 808,349
  • Market Cap: £8,621m
  • RiskGrade: 173
  • Beta: 0.57

Smith and Nephew Overview

Smith & Nephew plc is a portfolio medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. It is focused on the repair, regeneration and replacement of soft and hard tissue. It operates through three segments: Orthopaedics, Sports Medicine & ENT and Advanced Wound Management. Its Orthopaedics segment includes a range of hip and knee Implants used to replace diseased, damaged or worn joints, robotics-assisted and digital enabling technologies and services that helps surgeons, and trauma products used to stabilize severe fractures and correct hard tissue deformities. Its Sports Medicine & Ear, Nose and Throat (ENT) businesses offer advanced products and instruments used to repair or remove soft tissue.

1 Day Chart (24-12-2024)

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Smith and Nephew Financials

Latest F'cast
Div Yield 3.0% 0.0%
Div Cover 2.2 2.4
Op Mrgn 7.7% 15.7%
ROCE 9.1%  
Latest F'cast
P/E 15.0 13.9
PEG 12.2 n/a
Pr/Revenue 2.0 1.5
Pr/Book 2.1  
Latest F'cast
Revenue 6.4% -17.0%
PBT 23.4% 149.7%
EPS 1.2% -14.3%
DPS n/a -38.0%

Smith and Nephew Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-19 5,138.00 743.00 102.20¢ 22.5 22.5 +1% 37.50¢ 1.6%
31-Dec-20 4,560.00 246.00 64.60¢ 29.3 n/a -37% 37.50¢ 2.0%
31-Dec-21 5,212.00 586.00 80.90¢ 20.1 0.8 +25% 37.50¢ 2.3%
31-Dec-22 5,215.00 235.00 81.80¢ 17.0 17.0 +1% 37.50¢ 2.7%
31-Dec-23 5,549.00 290.00 82.80¢ 16.3 16.3 +1% 37.50¢ 2.8%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Smith and Nephew Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-24 5,779.77 908.96 70.95p 13.9 n/a -14% 29.17p 0.0%
31-Dec-25 6,065.68 1,058.73 83.53p 11.8 0.7 +18% 32.42p 0.0%
31-Dec-26 6,374.12 1,166.30 94.23p 10.5 0.8 +13% 35.83p 0.0%

Copyright © 2024 FactSet Research Systems Inc. All rights reserved.

Smith and Nephew Company Announcements

Director/PDMR Shareholding 20-Dec-2024 09:46 RNS
Holding(s) in Company 16-Dec-2024 11:50 RNS
Holding(s) in Company 12-Dec-2024 09:53 RNS

Smith and Nephew ShareCast News

Berenberg lowers Smtih and Nephew to 'hold' 06-Nov-2024 ShareCast
London close: Stocks mixed on eve of US presiden... 04-Nov-2024 ShareCast
Jefferies cuts Smith & Nephew target but stays o... 04-Nov-2024 ShareCast

Smith and Nephew Top Newspaper Links

Festive cheer for Smith & Nephew as shares jump ... 26-Dec-2014 Daily Mail
Smith & Nephew shares jump 10pc on Stryker bid r... 26-Dec-2014 Telegraph
MARKET REPORT: Bid talk boosts Smith & Nephew 26-Nov-2014 Express & Star

Latest Smith and Nephew Director Deals

Traded Action Notifier PriceAmountValue
19-Dec-24 Buy John Rogers 971.96p 71,920 £699,030.05
05-Dec-24 Sell Deepak Nath 981.20p 34,033 £333,931.81
05-Dec-24 Transfer From Deepak Nath 0.000p 83,057 £0.00

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Smith and Nephew Market Data

Currency UK Pounds
Share Price 986.00p
Change Today 9.20p
% Change 0.94 %
52 Week High 1,208.50
52 Week Low 917.60
Volume 808,349
Shares Issued 874.38m
Market Cap £8,621m
Beta 0.57
RiskGrade 173

Smith and Nephew Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
79.67% below the market average79.67% below the market average79.67% below the market average79.67% below the market average79.67% below the market average
54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average
Price Trend
12.18% below the market average12.18% below the market average12.18% below the market average12.18% below the market average12.18% below the market average
40.54% above the sector average40.54% above the sector average40.54% above the sector average40.54% above the sector average40.54% above the sector average
Income
5.42% below the market average5.42% below the market average5.42% below the market average5.42% below the market average5.42% below the market average
75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average
Growth
33.79% below the market average33.79% below the market average33.79% below the market average33.79% below the market average33.79% below the market average
94.44% below the sector average94.44% below the sector average94.44% below the sector average94.44% below the sector average94.44% below the sector average

What The Brokers Say

Strong Buy 6
Buy 4
Neutral 7
Sell 0
Strong Sell 1
Total 18
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Smith and Nephew Dividends

  Latest Previous
  Interim Final
Ex-Div 03-Oct-24 28-Mar-24
Paid 08-Nov-24 22-May-24
Amount 14.40¢ 23.10¢

Trades for 24-Dec-2024

Time Volume / Share Price
12:35 224,642 @ 986.00p
12:35 1 @ 986.00p
12:35 47 @ 986.00p
12:35 841 @ 986.00p
12:35 1,751 @ 986.00p

Smith and Nephew Key Personnel

CEO Deepak Nath
CFO John Rogers

Top of Page